Attached files
| file | filename |
|---|---|
| 10-K - 10-K - IRONWOOD PHARMACEUTICALS INC | a2202841z10-k.htm |
| EX-31.1 - EX-31.1 - IRONWOOD PHARMACEUTICALS INC | a2202841zex-31_1.htm |
| EX-21.1 - EX-21.1 - IRONWOOD PHARMACEUTICALS INC | a2202841zex-21_1.htm |
| EX-31.2 - EX-31.2 - IRONWOOD PHARMACEUTICALS INC | a2202841zex-31_2.htm |
| EX-32.1 - EX-32.1 - IRONWOOD PHARMACEUTICALS INC | a2202841zex-32_1.htm |
| EX-32.2 - EX-32.2 - IRONWOOD PHARMACEUTICALS INC | a2202841zex-32_2.htm |
| EX-10.14.2 - EX-10.14.2 - IRONWOOD PHARMACEUTICALS INC | a2202841zex-10_142.htm |
| EX-10.14.3 - EX-10.14.3 - IRONWOOD PHARMACEUTICALS INC | a2202841zex-10_143.htm |
QuickLinks -- Click here to rapidly navigate through this document
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements (Form S-8 Nos. 333-165227, 333-165228, 333-165229, 333-165230, and 333-165231) of our report dated March 30, 2011, with respect to the consolidated financial statements of Ironwood Pharmaceuticals, Inc. included in this Annual Report (Form 10-K) for the year ended December 31, 2010.
|
/s/ Ernst & Young LLP | |
Boston, Massachusetts |
||
March 30, 2011 |